ID | Treatment type | Follow-up time (months) | Complications n(%) | BR n(%) | DM n(%) | Survival rate, % | Survival time (months) | Deaths n(%) |
---|---|---|---|---|---|---|---|---|
1 | Salvage | 32.5 | 3 (75%) | 2 (50%) | 1 (25%) | Nx | Nx | 0 |
Primary | 61.8 | 5 (55.6%) | 2 (22.2%) | 7 (77.8%) | Nx | Nx | 1 (11.1%) | |
2 | Salvage | 39.4 | Nx | 1 (20%) | 0 | Nx | Nx | 0 |
3 | Primary | Nx | 1 (6.7%) | Nx | 0 | 5-year CSS: 82% 5-year BPFS : 51% | Nx | 0 |
4 | Salvage | 21 | Nx | Nx | 6 (15.8%) | Nx | Median CSS: 31 | 2 (5.3%) |
Primary | 25 | Nx | ||||||
5 | Salvage | 49.2 | 34 (55.7%) | Nx | Nx | 10-year CSS: 38% | Average CSS: 52.8 | Nx |
6 | Primary | 89 | 11 (64.7%) | Nx | 0 | 5-year BPFS: 62.2% 5-year CSS: 87.1% | Average OS: 156 | 9 (52.9%) |
7 | Primary | 35 | Nx | Nx | Nx | 5-year CSS: 44.5% 5-year OS: 39.8% 7-year CSS: 39.7% 7-year OS: 32.4% | Nx | 40 (64.5%) |